Skip to main content
. 2015 Mar 4;92(3):660–665. doi: 10.4269/ajtmh.14-0396

Table 1.

Description of the study validation methods

Implementation strength indicator Validation method Description
Validation at the health center/supervisor level
 (1) Percentage of HSAs currently working Supervisor records Record review; if no record was available, supervisor responded from memory
 (2) Percentage of HSAs trained in CCM Supervisor records
 (3) Percentage of HSAs supervised in the previous 3 months Supervisor records and monthly monitoring form Record review; if no record was available, supervisor responded from memory
 (4) Percentage of HSAs who received clinical mentoring in the previous 3 months
 (5) Percentage of HSAs supervised with reinforcement of clinical practice for the most recent supervision in the previous 3 months Supervision and mentoring checklists Review of most recent completed checklist; if no checklist was available, information was not captured
 (6) Percentage of HSAs with a drug stock-out in the previous 3 reporting months Monthly monitoring form review Review of six most recent monthly monitoring forms; if all six were not accessible, then data were recorded from the partial set*
Validation at the village clinic/HSA level
 (8) Percentage of HSAs with current stocks of CCM drugs/supplies Observation at VC Direct observation of drugs/supplies at HSA VC
 (9) Percentage of HSAs with minimum stocks of CCM drugs
 (10) Percentage of HSAs who have treated a sick child in the previous 3 months Register review Direct observation of CCM register at HSA VC

VC = village clinic.

*

HSAs were asked only about the stock-outs that had been reported to the health center through the monitoring form so that the information could be validated. It did not include recent stock-outs.